Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shaping Microbiome R&D's Future: Is Big Pharma Missing The Boat?

Executive Summary

The White House said the Obama administration plans to spend $121m under a new initiative to push the science of the microbiome forward. But few drug makers were among those who responded to the administration's call to action to support the initiative's overarching goals.

Advertisement

Related Content

Sanger Institute Spin-Out Microbiotica To Evaluate Bacterial Mixes
Home sweet microbiome: 10,000 microbial species occupy healthy humans

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC065188

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel